These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32282292)

  • 1. Liposome Circulation Time is Prolonged by CD47 Coating.
    Hayat SMG; Jaafari MR; Hatamipour M; Penson PE; Sahebkar A
    Protein Pept Lett; 2020; 27(10):1029-1037. PubMed ID: 32282292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of the pharmacokinetic characteristics of liposomal doxorubicin using CD47 biomimickry.
    Gheibihayat SM; Jaafari MR; Hatamipour M; Sahebkar A
    J Pharm Pharmacol; 2021 Mar; 73(2):169-177. PubMed ID: 33793801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin.
    Gheibi Hayat SM; Jaafari MR; Hatamipour M; Jamialahmadi T; Sahebkar A
    Expert Opin Drug Deliv; 2020 Jul; 17(7):1049-1058. PubMed ID: 32434390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD47 Functionalization of Nanoparticles as a Poly(ethylene glycol) Alternative: A Novel Approach to Improve Drug Delivery.
    Vandchali NR; Moadab F; Taghizadeh E; Tajbakhsh A; Gheibihayat SM
    Curr Drug Targets; 2021; 22(15):1750-1759. PubMed ID: 33563192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
    Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH
    Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stealth functionalization of biomaterials and nanoparticles by CD47 mimicry.
    Gheibi Hayat SM; Bianconi V; Pirro M; Sahebkar A
    Int J Pharm; 2019 Oct; 569():118628. PubMed ID: 31421198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy.
    Pasut G; Paolino D; Celia C; Mero A; Joseph AS; Wolfram J; Cosco D; Schiavon O; Shen H; Fresta M
    J Control Release; 2015 Feb; 199():106-13. PubMed ID: 25499917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer.
    Charrois GJ; Allen TM
    Biochim Biophys Acta; 2004 May; 1663(1-2):167-77. PubMed ID: 15157619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparosan-coated liposomes for drug delivery.
    Lane RS; Haller FM; Chavaroche AAE; Almond A; DeAngelis PL
    Glycobiology; 2017 Nov; 27(11):1062-1074. PubMed ID: 29044377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-coating of receptor-targeted drug nanocarriers with anti-phagocytic moieties enhances specific tissue uptake versus non-specific phagocytic clearance.
    Kim J; Sinha S; Solomon M; Perez-Herrero E; Hsu J; Tsinas Z; Muro S
    Biomaterials; 2017 Dec; 147():14-25. PubMed ID: 28923682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours.
    Gabizon A; Martin F
    Drugs; 1997; 54 Suppl 4():15-21. PubMed ID: 9361957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies.
    Goren D; Horowitz AT; Zalipsky S; Woodle MC; Yarden Y; Gabizon A
    Br J Cancer; 1996 Dec; 74(11):1749-56. PubMed ID: 8956788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PEG-liposome in DDS and clinical studies].
    Maruyama K
    Nihon Rinsho; 1998 Mar; 56(3):632-7. PubMed ID: 9549348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smart surface coating of drug nanoparticles with cross-linkable polyethylene glycol for bio-responsive and highly efficient drug delivery.
    Wei W; Zhang X; Chen X; Zhou M; Xu R; Zhang X
    Nanoscale; 2016 Apr; 8(15):8118-25. PubMed ID: 27025546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity.
    Shmeeda H; Amitay Y; Tzemach D; Gorin J; Gabizon A
    J Control Release; 2013 May; 167(3):265-75. PubMed ID: 23419948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
    Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
    Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD47-targeted bismuth selenide nanoparticles actualize improved photothermal therapy by increasing macrophage phagocytosis of cancer cells.
    Guo Z; Liu Y; Zhou H; Zheng K; Wang D; Jia M; Xu P; Ma K; Cui C; Wang L
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110546. PubMed ID: 31606701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution study of doxorubicin encapsulated in liposomes: influence of peptide coating and lipid composition.
    Almiñana N; Polo D; Rodríguez L; Reig F
    Prep Biochem Biotechnol; 2004 Feb; 34(1):77-96. PubMed ID: 15046298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models.
    Gabizon A; Tzemach D; Mak L; Bronstein M; Horowitz AT
    J Drug Target; 2002 Nov; 10(7):539-48. PubMed ID: 12683721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.